摘要
Various E-ring hydroxylated antofine and cryptopleurine analogues were designed, synthesized, and tested against five human cancer cell lines. Interesting structure-activity relationship (SAR) correlations were found among these new compounds. The most potent compound 13b was further tested against a series of nonsmall cell lung cancer (NSCLC) cell lines in which it showed impressive antiproliferative activity. Mechanistic studies revealed that 13b is able to down-regulate HSP90 and β-catenin in A549 lung adenocarcinoma cells in a dose-dependent manner, suggesting a potential use for treating hedgehog pathway-driven tumorigenesis.
原文 | 英語 |
---|---|
頁(從 - 到) | 6751-6761 |
頁數 | 11 |
期刊 | Journal of Medicinal Chemistry |
卷 | 55 |
發行號 | 15 |
DOIs | |
出版狀態 | 已發佈 - 8月 9 2012 |
對外發佈 | 是 |
ASJC Scopus subject areas
- 分子醫學
- 藥物發現